Trial Profile
Study Proposal - A Randomized Double-Blinded Study Comparing Adding Etoricoxib Versus Placebo to Female Patients With Fibromyalgia-Analysis of Organic and Psychiatric Measures.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Etoricoxib (Primary)
- Indications Fibromyalgia
- Focus Therapeutic Use
- 13 Jan 2016 Status changed from recruiting to completed according to results published in the International Journal of Clinical Practice.
- 13 Jan 2016 Primary endpoint of brief pain inventory has not been met, according to results published in the International Journal of Clinical Practice.
- 13 Jan 2016 Results published in the International Journal of Clinical Practice